Currently, building a modern pharmaceutical logistics system and constructing a comprehensive medical industry chain supply chain are important topics for pharmaceutical enterprises. From August 1st to 2nd, Yu Qingming, Secretary of the Party Committee and Chairman of China National Pharmaceutical Holdings, stated at the 2023 Semiannual Work Conference of China National Pharmaceutical Holdings held in Shanghai that "efforts should be made to build an enterprise innovation platform, enhance the capabilities of pharmaceutical smart supply chain services, and accelerate the construction of a world-class pharmaceutical circulation enterprise". Yu Qingming, Secretary of the Party Committee and Chairman of National Pharmaceutical Holdings, made a good start for the new "20 years". This year marks the 20th anniversary of the establishment of National Pharmaceutical Holdings. In the past 20 years, Sinopharm Holdings has taken the lead in implementing the mixed reform of state-owned enterprises, continuously promoting resource restructuring and innovation in business formats, and continuously achieving a leap of billions. In an interview, Yu Qingming stated that "in the past 20 years, China National Pharmaceutical Holdings has maintained a stable and progressive development trend, with improvement in quality. As of 2022, China National Pharmaceutical Holdings has an annual sales scale of 552.1 billion yuan, ranking 24th among the Fortune 500 Chinese listed companies in 2023 and first in the Chinese brand value 500 medical industry. Yu Qingming further introduced that Sinopharm Holdings always adheres to the concept of "protecting life, caring for health", continues to strengthen and optimize the core business of pharmaceutical trade and circulation, and continuously leads the industry in innovative business models such as the intelligent supply chain system of pharmaceuticals and medical devices. The three major formats of pharmaceuticals, medical devices, and pharmaceutical retail have achieved double-digit growth, steadily increasing market share, and continuously consolidating their leading position in the industry. As a pioneer and leader in the domestic ESG field, we continuously improve our governance level through sound management, share development results with society, and comprehensively serve the Healthy China strategy. Recently, we were successfully selected as the "Top 100 Chinese ESG Listed Companies" and ranked 10th. Looking ahead to future development, Yu Qingming stated that based on summarizing the three-year practical experience of state-owned enterprise reform, China National Pharmaceutical Holdings is accelerating the construction of a digital, integrated, platformized, and internationalized pharmaceutical and health industry chain and supply chain system, and firmly promoting the implementation of the "four beams and eight pillars, one hundred strong trillion" strategy. At present, China National Pharmaceutical Holdings is standing at a new starting point. Faced with the influence of policies, markets, and various factors, we must continue to consolidate the core competitiveness of pharmaceutical circulation, strengthen the core functions of various business formats, accelerate our progress towards building a world-class pharmaceutical circulation enterprise, and make a good start and step for China National Pharmaceutical Holdings in the new '20 years', "said Yu Qingming. The 20th National Congress of the Communist Party of China has made important arrangements for deepening the reform of state-owned assets and enterprises and enhancing their core competitiveness. Over the past 20 years, Sinopharm Holdings has formed a series of distinctive core competitiveness - with 120000 employees, nearly 1200 corporate enterprises, and 15000 pharmacies in China. The logistics hub of Dianqiang Netcom, deep grassroots distribution network, nationwide retail stores, and a smart supply chain management system that runs through various nodes of pharmaceutical circulation ensure the safe and timely supply of pharmaceutical equipment from all aspects, "Yu Qingming said, Behind a series of numbers are milestones built by generations of Chinese medicine professionals with professionalism, dedication, diligence, and precision. They are valuable wealth accumulated by Chinese medicine professionals after experiencing policy changes, competitive changes, technological innovation, and other challenges